Alpha Dna Investment Management LLC Alkermes Plc. Transaction History

Alpha Dna Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	BUY	$28.34 - $33.63 $628,751 - $746,115	22,186 New	22,186 $694,000
Q2 2021 Aug 10, 2021	SELL	$18.78 - $25.15 $1,802 - $2,414	-96 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$18.21 - $23.2 $1,092 - $1,392	60 Added 166.67%	96 $1,000
Q4 2020 Mar 24, 2021	BUY	$15.39 - $22.1 $554 - $795	36 New	36 $0

358

180M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.12B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.